RE: Redundancy money18 Jun 2024 09:37
The two directors who have been removed had good experience in the CBD field, however they lacked any experience in the critical areas that the company needs at the moment.
As such, they were hanging on to their positions and drawing fees that they could not justify, even if they were doing the best that they were able. A lot of times our confidence far outstrips both our knowledge and our ability.
The new directors have both the knowledge and the ability to take the company forward. This will be viewed in a positive light by the market. As I have judged previously, the price should be in the region of 5p when the suspension is lifted. However, any further positive news could push this higher, but I think this unlikely at the moment. However I'm more than happy to listen to alternative viewpoints if these are aired in a constructive manner.